1,8-naphthyridinone compounds and uses thereof
Abstract:
1,8-naphthyridinone compounds as modulators of an adenosine receptor are provided. The compounds may find use as therapeutic agents for the treatment of diseases mediated through a G-protein-coupled receptor signaling pathway and may find particular use in oncology.
Public/Granted literature
Information query
Patent Agency Ranking
0/0